Outcome and risk of ocular complications of managing children with chronic anterior uveitis with topical rimexolone 1

Purpose To investigate the efficacy and safety of 1% rimexolone ophthalmic suspension in children with chronic anterior uveitis under real-life conditions in a tertiary center. Methods This is a retrospective longitudinal study. Medical records were analyzed at baseline, 1, 3, 6 and 12 months before and after switching to rimexolone for best-corrected visual acuity (BCVA), oral steroid use, number of flares, IOP and anti-glaucoma management. Results Twenty-four patients (41 eyes) diagnosed with either anterior uveitis ( n = 25, 60.0%) or panuveitis ( n = 16, 40%) were enrolled. The mean age was 10.5 years (4–16 years). The number of patients requiring oral prednisolone reduced from 8 patients (32.0%) at baseline to 3 patients (20.0%) at 12 months ( P